Skip to main content
OpenTrials

Clinical trial condition

Stage IIB Prostate Cancer

Explore clinical trials studying Stage IIB Prostate Cancer. Study availability and eligibility vary by location and protocol.

32 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IIB Prostate Cancer trial results

Completed

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

NCT00589472

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

NCT01325311

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Lahey Hospital and Medical Center Burlington, Massachusetts, United States
View Trial Details
Completed

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

NCT00108732

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Baptist Cancer Institute Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions